Background
==========

The assessment of traditional risk factors is a basic element in the primary prevention of cardiovascular disease (CVD). New markers of increased risk or pre-symptomatic disease are being studied in order to refine risk assessment and to target the treatment of those at highest risk \[[@B1]\]. The vascular endothelium plays a central role in the pathogenesis of CVD \[[@B2]\]. The measurements of endothelial function are promising indicators of vascular health \[[@B2]\].

The term "endothelial dysfunction" refers to a broad alteration in endothelial phenotype and capacity to maintain vascular homeostasis \[[@B2],[@B3]\]. Endothelial dysfunction contributes to the initiation and progression of atherosclerotic disease and is an individual cardiovascular risk factor with prognostic value \[[@B2],[@B3]\]. Many interventions that reverse endothelial dysfunction also reduce cardiovascular risk, and one potential use for the measurements of endothelial function is the evaluation of interventions to reduce CVD risk \[[@B2]\].

The most commonly used method to assess endothelial function is to measure endothelium-dependent vasodilatation by using stimuli that increase the production of endothelium-derived nitric oxide \[[@B2]\]. The flow-mediated dilatation in the brachial artery can be measured by vascular ultrasound \[[@B4]\]. Peripheral arterial tonometry (PAT) is a novel method for evaluating endothelial function. It has been used in ambulatory settings and in large scale trials \[[@B5],[@B6]\]. PAT measures the increase in digital pulse volume amplitude during reactive hyperemia in relation to baseline. This response is reproducible, and has shown to be mainly dependent on nitric oxide \[[@B7],[@B8]\]. The response is attenuated and the PAT score is lower in patients with coronary endothelial dysfunction \[[@B9]\]. There is also a significant relationship between PAT measures and brachial artery ultrasound measures \[[@B10]\]. Endothelial dysfunction measured by PAT is associated with multiple cardiovascular risk factors \[[@B5],[@B10]-[@B13]\]. The changes in PAT-related endothelial function are reversible through effective interventions \[[@B14]-[@B16]\], and may be useful for the identification of patients at risk of cardiovascular adverse events \[[@B17]\].

This cross-sectional study aims to investigate the association between the index of endothelial function measured by PAT, F-RHI (Framingham reactive hyperemia index), and heterogenous cardio-metabolic risk factors in a population of asymptomatic municipal workers.

Methods
=======

Study design
------------

This study is part of the larger Nuadu interventional study, which aimed to create new methods of early recognition of people at health risks and a multi-factorial lifestyle intervention suitable for occupational health care \[[@B18]\]. Study subjects were selected from among municipal workers (n = \~10900) in the City of Espoo, based on a health questionnaire. A total of 4134 (38%) replied. The questionnaire included items on physical activity, sleep, smoking, drinking, nutrition, physical and mental stress and strain, perceived health, and work ability. The inclusion criteria were willingness to participate in the intervention, age between 30--55 years, and a subjectively estimated work ability of 7--9 on a scale of 0--10, 10 being lifetime best \[[@B19]\]. Another important criterion was the willingness to change health behaviour in one or more of the following target areas within the next six months: weight control, physical activity, alcohol consumption, eating habits, smoking or sleeping habits. Subjects also had to have an increased diabetes risk on the basis of a questionnaire (12--20 points in the Diabetes risk test) \[[@B20]\] or at least two of the following risk factors: body mass index (BMI) 27--34.9, low physical activity level \[[@B21]\], sleep deprivation (difference between self-estimated need of sleep and actual sleeping time greater than two hours), risky alcohol consumption based on AUDIT-C \[[@B22],[@B23]\], smoking, not eating vegetables daily and/or not eating during the working day. Pregnant women were excluded from the study. Among the respondents, 783 (19%) employees fulfilled the inclusion criteria. Of these, 352 were randomly selected for the intervention study. Seventeen people who had a BMI of 35 or higher were excluded.

Participants of the intervention study answered the basic Nuadu intervention questionnaire, underwent the baseline measurements of the intervention, and received personal feedback on their situation. Two randomised groups participated in health behaviour interventions and one served as the control. The questionnaires and measurements were repeated one year later. The results presented here are those of the baseline measurements. Due to this, two intervention groups and a control group were pooled in this article.

All subjects gave informed consent and the study protocol was approved by the Coordinating Ethics Committee of the Hospital District of Helsinki and Uusimaa.

Physiological measurements
--------------------------

Every participant underwent a medical physical examination before the physiological measurements. We measured height, weight and waist circumference (WC). Body composition was analysed by eight-polar bioelectrical impedance (BIA) (Body 3.0, Biospace Company Ltd, Seoul, South Korea). The blood samples were analysed according to the standard methods of the laboratory of Helsinki University Central Hospital (Accredited laboratory, <http://www.huslab.fi>). They included total cholesterol, HDL cholesterol, triglycerides, fasting glucose, glycated hemoglobin (HbA1c) and high sensitivity C-reactive protein (hs-CRP). LDL cholesterol was estimated using the Friedewald equation \[[@B24]\].

Coding of dichotomous risk factors
----------------------------------

Dichotomous risk factors were coded as 0 = absence of risk factor, and 1 = presence of risk factor. The criteria for coding the presence of risk factors were as follows: 1. Current smoking based on the intervention questionnaire; regular smoker, or casual smoker who was a regular smoker in the earlier health questionnaire; 2. Family history of cardiovascular disease: myocardial infarction, coronary revascularization, or sudden death of father or other male first degree relative before 55 years of age, or mother or other female first degree relative before 65 years of age; 3. Hypertension treatment or lipid lowering treatment: medication used regularly or often; 4. Impaired fasting glucose or diabetes: in laboratory measurements a fasting glucose of ≥ 6.1 mmol/l; 5. Hypertension: systolic blood pressure of ≥ 140 mm Hg and/or diastolic blood pressure of ≥ 90 mm Hg; 6. Dyslipidemia: an LDL cholesterol of \< 3 mmol/l, triglycerides of \> 2, an HDL cholesterol of \< 1 mmol/l and/or a total to HDL ratio of \> 4. In regression models, male sex was also considered a risk factor.

Measurements of endothelial function
------------------------------------

We measured the endothelial function of 312 participants. Digital pulse volume amplitude was measured and analysed using the PAT method (Endo-PAT2000, Software version 3.0.3, Itamar Medical Ltd, Caesarea, Israel). The principle of PAT has been described earlier \[[@B10]\]. During the assessment, the participant was in a supine position in a comfortable, quiet, and thermoneutral environment, with the lights dimmed.

Pneumatic probes were placed on the index finger of each hand, and a blood pressure cuff was placed on the left upper arm. The left hand underwent reactive hyperemia testing and the contralateral hand served as the control. The participants were allowed to lie down for a couple of minutes before the recording of the pulsatile volume changes began. After five minutes of baseline measurement, the blood pressure cuff was rapidly inflated to 200 mm Hg or 60 mm Hg above systolic blood pressure, whichever was higher. Occlusion lasted for exactly five minutes, after which the blood pressure cuff was deflated to induce reactive hyperemia. We continued recording for five more minutes.

The PAT data was analysed by a computerised operator independent algorithm with Endo-PAT2000 software. The manufacturer's basic index of vascular reactivity, RHI, is defined as the ratio of postdeflation pulse amplitude to the baseline pulse amplitude. The average amplitude of a one-minute period of PAT signal, starting one minute after cuff deflation, is divided by the average amplitude of the 2.5-minute period of PAT baseline signal before cuff inflation. This ratio is normalized to the corresponding ratio from the control arm to compensate for potential systemic changes in the amplitude. The automatic calculation of RHI has an imbedded correction factor to deal with the strong negative correlation between the baseline pulse amplitude and the relative response. Baseline pulse amplitude itself correlates with many cardiovascular risk factors, and the correction factor may actually hide some relevant information. Thus in this study, in addition to RHI, we calculated and used an index without the correlation factor. F-RHI was defined as F-RHI = ln(RHo/RHc), where RHo and RHc are the mean pulse amplitudes of the period 1.5--2 minutes after cuff deflation divided by mean baseline amplitudes in the occluded arm and control arm, respectively \[[@B11]\]. F-RHI is more highly associated with cardiovascular risk factors and has also shown to be more reproducible than RHI in adolescents \[[@B7]\].

Statistical methods
-------------------

A linear regression model was used to determine the association of F-RHI with sex. We used twenty separate sex-adjusted linear regression models to find the association of F-RHI with each of the following cardiovascular and metabolic risk factors: age, BMI, WC, body fat percentage assessed by BIA, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, fasting glucose, HbA1c, hs-CRP, systolic and diastolic blood pressure, resting heart rate, rate-pressure product, hypertension treatment, lipid lowering treatment, impaired fasting glucose or diabetes, family history of CVD, and current smoking.

The normality of the variables was tested using the Kolmogorov-Smirnov test. CRP values were log-transformed for the regression models to obtain normal distribution.

We selected the variables that were allowed to enter the multivariable regression model in advance to avoid co-linearity. As regards possible co-linear variables, we selected the potential covariate based on current knowledge on the importance of the risk factors and the reliability of the method used to measure it. In the multivariable regression model we used a stepwise method for variable selection. The criteria for entering or keeping the variable in the model were p \< 0.05 and p \< 0.1, respectively. All analyses were performed using SPSS 15.0 for Windows (SPSS Inc., Chicago, IL, USA).

Results
=======

Subject characteristics
-----------------------

Subject characteristics are presented in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

###### 

Subject characteristics tabulated by sex

  **Cardiovascular and metabolic risk factors**   **Women (n = 254)**   **Men (n = 58)**   **p**
  ----------------------------------------------- --------------------- ------------------ ----------
  Age (y)                                         44.6 ± 6.7            43.5 ± 7.6         0.278
  Body mass index (kg/m^2^)                       27.2 ± 4.1            27.6 ± 3.6         0.406
  Waist circumference (cm)                        90.4 ± 11.3           100.0 ± 10.1       \<0.0001
  Body fat percentage (%)                         31.6 ± 6.6            22.2 ± 6.0         \<0.0001
  Total cholesterol (mmol/l)                      4.7 ± 0.8             5.0 ± 1.0          0.039
  HDL cholesterol (mmol/l)                        1.6 ± 0.4             1.3 ± 0.3          \<0.0001
  LDL cholesterol (mmol/l)                        2.6 ± 0.7             3.1 ± 0.9          \<0.001
  Triglycerides (mmol/l)                          1.0 ± 0.6             1.4 ± 0.7          \<0.001
  Fasting glucose (mmol/l)                        5.4 ± 0.8             5.5 ± 0.6          0.226
  Glycated hemoglobin (%)                         5.5 ± 0.4             5.6 ± 0.3          0.264
  High sensitivity C-reactive protein (mg/l)      2.11 ± 3.97           1.96 ± 3.08        0.912
  Systolic blood pressure (mm Hg)                 121 ± 13              125 ± 14           0.015
  Diastolic blood pressure (mm Hg)                79 ± 8                81 ± 9             0.041
  Resting heart rate (bpm)                        69 ± 10               69 ± 11            0.619
  Rate-pressure product                           84 ± 16               86 ± 18            0.327
  Framingham Reactive Hyperemia Index             0.676 ± 0.401         0.325 ± 0.293      \<0.0001
  Reactive Hyperemia Index                        2.272 ± 0.617         1.903 ± 0.403      \<0.0001

Values are mean ± SD. P-value for differences of means between sexes.

###### 

Risk factors and medication tabulated by sex

  **Cardiovascular and metabolic risk factors**   **Women (n = 254)**   **Men (n = 58)**   **p**
  ----------------------------------------------- --------------------- ------------------ ----------
  Current smoking                                 20.9                  25.9               0.406
  Body mass index \> 25                           65.4                  81.0               0.021
  Family history of cardiovascular disease        28.0                  20.7               0.259
  Impaired fasting glucose or diabetes            9.4                   12.5               0.491
  Hypertension treatment                          11.0                  5.2                0.179
  Lipid lowering treatment                        3.1                   6.9                0.189
  Hypertension                                    13.4                  24.1               0.041
  Dyslipidemia                                    31.1                  67.9               \<0.0001

Values are percentages, p-value for chi-square test.

Associations of F-RHI with cardiometabolic risk factors
-------------------------------------------------------

Male sex was associated with lower F-RHI in the separate linear regression model.

Separate sex-adjusted linear regression models were used to find the association of F-RHI with each of the other risk factors. In these models WC, fasting glucose, glycated hemoglobin, triglycerides, body fat percentage, BMI, current smoking, and impaired fasting glucose or diabetes were inversely associated with F-RHI. The inverse relationship between F-RHI and C-reactive protein was nearly significant (p = 0.085). HDL cholesterol (Figure [1](#F1){ref-type="fig"}) and resting heart rate were positively associated with F-RHI. No significant relationships were found between F-RHI and age, systolic or diastolic blood pressure, pulse pressure, rate-pressure product, total cholesterol, LDL cholesterol, lipid lowering treatment, hypertension treatment or family history of CVD. Table [3](#T3){ref-type="table"} shows the results.

![**F-RHI and HDL cholesterol.** F-RHI and HDL cholesterol values. Plot showing data points labelled separately for men and women and fitted regression line adjusted for sex.](1471-2261-13-83-1){#F1}

###### 

Sex-adjusted associations of risk factors with F-RHI

  **Cardiovascular and metabolic risk factors**         **Beta(se)**    **p**      **Partial correlation**
  ----------------------------------------------------- --------------- ---------- -------------------------
  Sex                                                   -0.352(0.056)   \<0.0001   -0.337
  Age                                                   -0.004(0.003)   0.185      -0.075
  Body mass index                                       -0.29(0.005)    \<0.0001   -0.304
  Waist circumference                                   -0.10(0.002)    \<0.0001   -0.280
  Body fat percentage                                   -0.011(0.003)   \<0.001    -0.194
  Total cholesterol                                     0.011(0.025)    0.656      0.025
  HDL cholesterol                                       0.310(0.056)    \<0.0001   0.302
  LDL cholesterol                                       -0.025(0.029)   0.390      -0.049
  Triglycerides                                         -0.123(0.035)   \<0.001    -0.197
  Fasting glucose                                       -0.100(0.029)   \<0.001    -0.193
  Glycated hemoglobin                                   -0.147(0.061)   0.017      -0.136
  Log-transformed high sensitivity C-reactive protein   -0.024(0.014)   0.085      -0.100
  Systolic blood pressure                               0.00(0.002)     0.968      0.002
  Diastolic blood pressure                              -0.001(0.003)   0.825      -0.013
  Resting heart rate                                    0.005(0.002)    0.023      0.130
  Rate-pressure product                                 0.002(0.001)    0.084      0.099
  Hypertension treatment                                -0.073(0.073)   0.316      -0.057
  Lipid lowering treatment                              -0.031(0.113)   0.786      -0.015
  Impaired fasting glucose or diabetes                  -0.140(0.070)   0.047      0.113
  Family history of cardiovascular disease              0.004(0.049)    0.940      0.004
  Smoking                                               -0.152(0.052)   0.004      -0.164

Slope (standard error), p-value, partial correlation coefficient.

For multivariable analysis, we selected the variables that were allowed to enter the model in advance. Sex, BMI, current smoking, fasting glucose, triglycerides, HDL cholesterol, resting heart rate and C-reactive protein were significantly or nearly significantly associated with F-RHI in separate sex-adjusted models and were allowed to enter the multivariable model. In addition, age, LDL cholesterol, blood pressure and family history of CVD were allowed to enter the model as strong risk factors for CVD or diabetes. The variables selected by the stepwise procedure for the final model from those listed above were HDL cholesterol, sex, BMI and current smoking. This model explains 28.3% of the variability in F-RHI. Table [4](#T4){ref-type="table"} shows the results.

###### 

Final stepwise multivariable regression model

  **Cardiovascular and metabolic risk factors**   **Beta(se)**     **p**       **Partial correlation**
  ----------------------------------------------- ---------------- ----------- -------------------------
  HDL cholesterol                                 0.240 (0.060)    \<0.0001    0.229
  Sex                                             -0.264 (0.057)   \<0.00001   -0.249
  Body mass index                                 -0.026 (0.006)   \<0.00001   -0.248
  Smoking                                         -0.154 (0.050)   0.0022      -0.157
  ^1^Model R^2^                                   0.283                        

Slope (standard error), p-value and partial correlation and ^1^square of multiple correlation coefficient for model.

Additional analysis
-------------------

To further estimate if the risk factors play differently in men and women we made separate multivariable models for the two sexes. The variables that were selected for the final model for women were HDL cholesterol, BMI and smoking. The model explains 20.0% of the variability in F-RHI. As regards men, only BMI entered the model, which explains 13.8% of the variability. Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"} show the results.

###### 

Stepwise multivariable regression model for women

  **Cardiovascular and metabolic risk factors**   **Beta(se)**     **p**      **Partial correlation**
  ----------------------------------------------- ---------------- ---------- -------------------------
  HDL cholesterol                                 0.282 (0.064)    \<0.0001   0.273
  Body mass index                                 -0.024 (0.006)   \<0.001    -0.244
  Smoking                                         -0.157 (0.057)   0.007      -0.161
  ^1^Model R^2^                                   0.200                       

Slope (standard error), p-value, partial correlation and ^1^square of multiple correlation coefficient for model.

###### 

Stepwise multivariable regression model for men

  **Cardiovascular and metabolic risk factors**   **Beta(se)**     **p**     **Partial correlation**
  ----------------------------------------------- ---------------- --------- -------------------------
  Body mass index                                 -0.031 (0.011)   \<0.007   -0.371
  ^1^Model R^2^                                   0.138                      

Slope (standard error), p-value, partial correlation and ^1^square of multiple correlation coefficient for model.

Discussion
==========

Several cardiovascular and metabolic risk factors were associated with lowered endothelial function, measured by the PAT method, among those at risk of diabetes and cardiovascular disease. HDL cholesterol, current smoking, sex and body mass index explain more than a fourth of the variability in F-RHI.

As in previous studies, lower F-RHI was strongly associated with male sex in the separate linear regression model and the multivariable model \[[@B11],[@B13]\]. Since vascular function and development of cardiovascular disease differ between the sexes, it would be useful to study men and women separately instead of using sex as a covariate \[[@B25]\]. We performed additional analyses to find possible sex differences in associations between F-RHI and risk factors, but because of the low proportion of male subjects, we were unable to build a reliable model for men alone.

Lower F-RHI was strongly associated with obesity. The strongest single association we found was between F-RHI and BMI. Similar results can be obtained with body fat percentage or WC. In separate sex-adjusted models, all the inter-correlated measures of obesity; body mass index, waist circumference and body fat percentage measured by bioelectrical impedance analysis, were related to lower F-RHI. Of these, BMI was chosen as a candidate for the multivariable model and thus entered the model. This observation was in accordance with earlier studies \[[@B11],[@B13]\].

Disturbed lipid profile associated with lower F-RHI. In separate sex-adjusted models, high HDL cholesterol was associated with higher F-RHI, and high triglycerides associated with lower F-RHI. HDL cholesterol entered the multivariable model, and was one of the strongest predictors of F-RHI. However, there were no associations between F-RHI and total cholesterol, LDL cholesterol, or lipid-lowering treatment. The lipid values in the study population were better than those of the Finnish working age population in general \[[@B26]\]. One study with dominantly male subjects found a significant association between LDL cholesterol and lower PAT score, but none with HDL cholesterol, triglycerides or hyperlipidemia treatment \[[@B13]\]. Hamburg et al. found significant associations between lower F-RHI and total/HDL cholesterol, triglycerides and lipid-lowering treatment \[[@B11]\].

The findings concerning diabetes, fasting glucose and current smoking also support earlier studies \[[@B11]\].

Inflammation plays an important role in the pathogenesis of atherosclerosis \[[@B27]\]. We found no significant association between a marker of systemic inflammation, hs-CRP and F-RHI, although there was a modest non-significant association between higher log-transformed hs-CRP and lower F-RHI in the sex-adjusted model.

Age was not associated with F-RHI in the sex-adjusted model or in the multivariable analysis. It is possible that the range and distribution of age in our study population was not sufficient to show a possible relation. Earlier studies have shown a small but paradoxically positive association between advancing age and higher F-RHI \[[@B11]\], or no association at all between age and F-RHI \[[@B13]\].

Associations between F-RHI and blood pressure or resting heart rate were modest and somewhat counterintuitive. We found no association between F-RHI and systolic or diastolic blood pressure. Higher resting heart rate was paradoxically associated with higher F-RHI in the sex-adjusted model, although the beta coefficient was very small. Truschel et al. \[[@B13]\] found a significant but counterintuitive positive association between F-RHI and systolic blood pressure, but no relationship with resting heart rate \[[@B13]\]. Hamburg et al., conversely found an association between lower F-RHI and higher heart rate \[[@B11]\].

Blood pressure values in our study population were quite low compared to the Finnish working-age population in general \[[@B26]\]. More hypertensive data might possibly provide better information on the association.

Although the result of the PAT measurement, F-RHI, is mainly nitric oxide dependent, it is likely to be a combination of macro- and micro-vascular reactivity and affected by skin blood flow changes \[[@B28]\]. It is possible that the hyperemic response in the fingertip microvessels differs from other vascular beds \[[@B11]\]. This study confirms some of the associations found earlier between F-RHI and certain risk factors. Many of the established cardio-metabolic risk factors are associated with lower F-RHI as expected, but in this study the relationships with age, blood pressure and heart rate in particular are not parallel with the results of other studies, and need further investigation.

The study's strengths lie in the relatively large sample size and a good coverage of municipal workers at intermediate cardio-metabolic risk. We were also able to determine a comprehensive set of risk factors and study their associations with a novel measure of endothelial function.

One limitation of this analysis is its cross-sectional design. In addition, the number of male subjects was low, because the proportion of females among Finnish municipal workers is commonly significantly higher. Measurements of vascular reactivity were not carried out in a fasting state due to the study design, although the subjects were instructed to eat only lightly before the measurements. A study using an ultrasound technique for measuring endothelial function suggests that strict requirements for fasting conditions may be unnecessary \[[@B29]\].

The menstrual cycle phase was not controlled for. The women ranged from peri- to post-menopausal, but information regarding hormonal status or the use of menopausal hormones was not collected. In addition to sex, hormonal status contributes to and modulates the development of cardiovascular disease and should be taken in to account in future study design \[[@B25]\].

The study sample consisted of Caucasian people of European origin, thus the findings may not apply outside this population.

Conclusions
===========

In conclusion, the index of endothelial function, F-RHI, measured by PAT is associated with several cardio-metabolic risk factors; low HDL cholesterol level, male sex, overweight and current smoking being the most important predictors of a lowered F-RHI. A large part of the variation in F-RHI is still explained by other factors, and relationships between F-RHI and age or hemodynamic indices in particular need further investigation.
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